CanScreen5
CanScreen5 aggregates and harmonizes international cancer screening program data to report and evaluate the status and performance of breast, cervical, and colorectal cancer screening programs.
Key Features:
- Harmonized criteria and indicators: Uses a defined, harmonized set of criteria and indicators to standardize reporting across countries.
- Data aggregation: Aggregates screening program data from participating countries into a central repository.
- Data validation: Validates submitted data to ensure reliability and standardization across national contexts.
- Primary data source: Receives data primarily from Ministries of Health in participating countries.
- Scope and coverage: Compiled data from 84 countries as of September 2022, including breast cancer screening programs (57 countries), cervical cancer screening programs (75 countries), and colorectal cancer screening programs (51 countries).
- Reported coverage ranges: Documents country-level screening coverage ranges such as breast cancer 1.7% (Bangladesh) to 85.5% (England, United Kingdom), cervical cancer 2.1% (Côte d'Ivoire) to 86.3% (Sweden), and colorectal cancer 0.6% (Hungary) to 64.5% (Netherlands).
- Performance variability: Captures substantial variability in compliance with further assessment protocols and in detection rates of precancers and cancers across programs.
- Data completeness assessment: Identifies insufficient data availability for robust estimation of some performance indicators.
- Quality assurance emphasis: Highlights the need to integrate quality assurance protocols within robust information systems.
- Program organization assessment: Documents heterogeneity in program organization and the need for resource-stratified approaches in resource-limited settings.
Scientific Applications:
- Performance evaluation: Evaluate status and performance metrics of breast, cervical, and colorectal cancer screening programs across countries.
- Comparative analysis: Compare screening coverage and program organization heterogeneity between countries and regions.
- Gap identification: Identify gaps in compliance with further assessment protocols and variability in detection rates of precancers and cancers.
- Data quality improvement: Inform priorities for integrating quality assurance protocols into screening information systems.
- Resource-stratified planning: Support tailoring and stratification of screening strategies according to national resource constraints.
- Policy guidance: Provide evidence for policymakers and public health officials to inform program improvement and resource allocation.
Methodology:
Aggregates and validates country-level screening program data using a harmonized set of criteria and indicators with primary data sourced from Ministries of Health, compiling reported indicators (coverage, compliance, detection rates) as of September 2022.
Topics
Details
- Cost:
- Free of charge
- Tool Type:
- web application
- Operating Systems:
- Mac, Linux, Windows
- Added:
- 12/1/2023
- Last Updated:
- 11/24/2024
Operations
Publications
Zhang L, Mosquera I, Lucas E, Rol ML, Carvalho AL, Basu P, Sadowski D, Natasha B, Budd A, Nessa A, De Brabander I, Haelens A, Pringels S, Tairo J, Hofvind S, Burrion JB, Valerianova Z, Tinmouth J, Law C, Ebenuwah S, McCurdy B, Janik B, Pupwe G, Groeneveld LF, Skare GB, Layne P, Sarkeala T, Chaila MJ, Kaminski M, Kinel B, Lissowska J, Mumukunde I, Rodrigues V, Rodríguez R, Sanz EP, Alberdi RZ, Ronco G, Antoljak N, Nakić D, Plazanin D, Parun AŠ, Goossens M, Nowakowski A, de Koning H, Dams E, Martin A, Epermane M, Jankovska N, Antle S, Fracheboud J, Toes-Zoutendijk E, van Agt HME, Budewig K, Stomper B, Anttila A, McLeish S, Ramssl-Sauer A, Ziniel G, Kyprianou T, Pavlou P, Kaliva F, Tsantidou M, Zhang S, Xu H, Mushtaq W, Barragán BP, Montalvo A, de la Torre Santos AV, Guertin M, Fournier S, Duport N, Májek O, Ngo O, Ivanuš U, Jarm K, Primic-Zakelj M, de Miranda Corrêa F, Migowski A, Cancela M, Gallardo P, Fattore G, Puello A, Polanco V, Elizaga NA, Fabri V, Mantellini P, Zappa M, Kellen E, Lynge E, Kääb-Sanyal V, Malek D, Chami Y, Ivanauskiene R, Bandhoe N, Dillenbourg C, Heckters K, Scharpantgen A, Ruiz OM, González GM, Arenas E, Cacacho EAP, Pomata A, Navarro E, Mencia M, Ruiz GA, Campoverde R, Camel C, Donis R, Sandoval YI, García H, Roldán OI, del Carmen Moreno T, Velado MM, Merino G, Ríos JA, Marte S, Hernández RO, Chacón MA, Ruiz XI, del Carmen Hernández Vivas X, González RI, Ruiz DIM, Ortega L, Orbegozo AM, Haro CAC, Dalmas M, Unlu F, Abousselham L, De Waldt R, Buys C, Hanna Y, Williams C, Ottey L, Philbert-Cyr S, Emmanuel C, Jemmott A, de Miranda NAA, Kioupi S, Asnake TM, Attia AA, Tshisimogo G, Seema L, Banda JC, Mustapha FI, Mugolo RP, de Alice Miguel Juliao R, Nyangasi M, Mwenda V, Ferreira ST, Barbosa C, Makua M, Bakare YHJ, Charles M, Charles L, Edwards-France V, Sewtahal C, Kebirungi B, Rwabinumi MF, Williams V, Zachariah O, Scott A, Deleveaux C, Campbell M, Ferreira C, Perera S, Silva P, Kumarapeli V, Grant-Tate M, Tulloch C, Saika K, Lee K, Jun JK, Mukete SF, Dimitrov P, Momkuviene V, Zaksas V, Veerus P, Bric TK, Mlakar DN, Škrjanec AL, Zakotnik JM, Skhirtladze T, Xuereb S, Colquhoun C, Sangrajrang S, Eshwar K, Stanners G, Black R, Andreassen T, Budai A, Döbrõssy L, Kovács A, Nicula F, Portillo I, Altzibar JM, Arenaza E, Simango N, Espinàs JA, Glinton-Rolle C, Anews-Barr J, Capote M, Fazzino M, Armstrong C, Gamble A, Mc Innes K, Wright S, Clayton H, Latinovic R, Mackie A, Rimmer J, Hall C, Elfström KM, Törnberg S, Zorzi M, Leja M, Rezeberga D, Hagenimana M, Hamers F, Rogel A, Assogba F, Fitzpatrick P, Arbyn M, Figueroa J, Rovelo A, Salinas E, Argüello EY, Castillo AM, Rosas V, Špánik S, Houmann MR, Johansen D, Dillner J, Oswal K, Huang Y, Siala IM, Candeur M, Hoeck S, Borras JM, Bleyen L, Guzha BT, Olivier AYM, Fasching E, Vienna AGGÖ, Taohid T, Bencomo WB, Tejada D, Valletta JP, Nisbett J, Baptiste D, Layne MA. CanScreen5, a global repository for breast, cervical and colorectal cancer screening programs. Nature Medicine. 2023;29(5):1135-1145. doi:10.1038/s41591-023-02315-6. PMID:37106168. PMCID:PMC10202799.